Northern Trust Corp I Bio, Inc. Transaction History

Northern Trust Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.23 - $0.46 $325,450 - $650,900	-1,415,002 Reduced 79.19%	371,951 $98,000
Q1 2022 May 13, 2022	SELL	$0.3 - $0.61 $34,471 - $70,092	-114,905 Reduced 6.04%	1,786,953 $765,000
Q4 2021 Feb 08, 2022	SELL	$0.55 - $1.04 $19,870 - $37,573	-36,128 Reduced 1.86%	1,901,858 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$1.06 - $1.52 $68,167 - $97,749	-64,309 Reduced 3.21%	1,937,986 $2.05 Million
Q2 2021 Aug 13, 2021	SELL	$1.22 - $1.65 $227,991 - $308,348	-186,878 Reduced 8.54%	2,002,295 $3.02 Million
Q1 2021 May 12, 2021	BUY	$1.18 - $2.62 $277,151 - $615,369	234,874 Added 12.02%	2,189,173 $3.37 Million
Q4 2020 Feb 11, 2021	BUY	$1.05 - $2.24 $1.13 Million - $2.42 Million	1,079,972 Added 123.52%	1,954,299 $2.05 Million
Q3 2020 Nov 16, 2020	BUY	$1.7 - $6.41 $299,864 - $1.13 Million	176,391 Added 25.27%	874,327 $1.78 Million
Q2 2020 Aug 14, 2020	BUY	$0.87 - $2.46 $550,818 - $1.56 Million	633,125 Added 976.88%	697,936 $1.55 Million
Q1 2020 May 14, 2020	BUY	$0.22 - $2.45 $11,106 - $123,683	50,483 Added 352.34%	64,811 $69,000
Q2 2018 Aug 14, 2018	BUY	$0.83 - $2.1 $11,892 - $30,088	14,328 New	14,328 $13,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.